 Periodic discharges (PDs) was associated with high rates of comorbidities and mortality. 2  Old age was the strongest predictor of mortality in patients with PDs.
Clinical Correlation and Prognostic Implication of Periodic EEG
Due to its equivocal nature, the use of 'epileptiform' is no longer recommended, and the term 'periodic discharges' (PDs) has been suggested to be more appropriate (Hirsch et al., 2013) .
Despite increasing amounts of research on PDs, their prognostic value and clinical implication remain controversial, and large studies on these issues are lacking. One casecontrol study reported a decrease in Modified Rankin Scale score in 62% of patients with PDs, but a mortality rate of only 5% (Sainju et al., 2015) . In contrast, a higher mortality rate of 34% to 41% has been reported in long-term follow-up studies (Kate et al., 2012; Walsh and Brenner, 1987) . Some authors have suggested that PDs are initial ictal patterns (Garzon et al., 2001 ) and that they are highly associated (50% to 92% of cases) with the occurrence of clinical seizures (Baykan et al., 2000; Fitzpatrick and Lowry, 2007; Garcia-Morales et al., 2002; Orta et al., 2009; Sainju et al., 2015; Walsh and Brenner, 1987) . Other authors have suggested that PDs are simply markers of non-specific brain injury that are often accompanied by underlying comorbidities, and that clinicians should treat the underlying infection or inflammatory condition without the use of antiepileptic drugs (AEDs) (Maingueneau et al., 1999; Nakamura et al., 2002; Shimada et al., 1989) . Therefore, whether PDs should be treated with AEDs remains unclear. The aim of the current retrospective cohort study was to evaluate the characteristics and prognostic factors regarding different PD patterns and the potential influence of AED treatment.
Methods

Study subjects and EEG data collection
We searched our EEG database for all 20-minute routine EEG recordings performed during a 17-year period (January 1, 1999 to December 31, 2015) using the following keywords:
repetitive discharge, periodic discharge, periodic epileptiform discharge, lateralized periodic discharge, periodic lateralized epileptiform discharge, bilateral independent periodic discharge, bilateral independent periodic lateralized epileptiform discharge, generalized periodic discharge, generalized periodic epileptiform discharge and their abbreviations PD, PED, LPD, PLED, BiPD, BiPLED, GPD, and GPED. The EEG recordings were obtained using the 10-20
International System of electrode placement. For the purposes of this study, we further categorized the PDs as LPDs, BIPDs, or GPDs. LPDs were defined as unilateral and bilateral synchronous but asymmetric, focal or regional periodic patterns. BIPDs were defined as bilateral independent, asynchronous, and lateralized periodic patterns, and GPDs were defined as bilateral, bisynchronous and symmetric periodic patterns. When a patient had more than one EEG recording available, we only analyzed the first that showed evidence of a PD. This study was approved by the Institutional Review Board of Chang Gung Medical Foundation (201600678B0).
Clinical data collection
Historical clinical data were obtained by medical record review and included age, gender, etiology, occurrence and type of recent clinical seizures, and the administration of AEDs.
Recent clinical seizures were defined as at least one clinical seizure that occurred within 1 week after the appearance of PDs.
A retrospective chart review of neuroimaging findings and other investigations was conducted for each patient to determine the primary underlying etiology. The etiologies of the patients' diseases related to the time of the EEG recording included stroke (ischemic or hemorrhagic), anoxic encephalopathy, central nervous system (CNS) infection, systemic infection requiring treatment with antibiotics, Creutzfeldt-Jakob disease, metabolic derangements (any of the following: liver enzymes > twice the normal upper limit, elevated ammonia level, creatinine level > 1.5 mg/dL, hemoglobin < 8.0 mg/dL, sodium level < 125 or > 150 mEq/L), brain tumor, trauma, and carbapenem-related causes. Cefepime encephalopathy was considered to be a separate entity from drug-related causes due to its distinct pathophysiology in critically ill patients.
The patients' functional outcomes were assessed at discharge or at an outpatient followup visit within 1 month after the diagnostic EEG. The level of functional outcome was classified as being independent (the patients could carry out their normal activities of daily living), dependent (the patients could not carry on without assistance), and death.
Statistical analysis
All statistical analyses were performed using SPSS v.22.0 (SPSS Inc., Chicago, IL, USA).
Descriptive summaries were reported as mean ± standard deviation for numerical variables, and as number (percentage) for categorical variables. The χ 2 test was used for statistical analysis of variables. Conditional univariate and multivariate logistic regression models were used to analyze associations between functional outcomes and predictive factors. The independent variables used in the univariate logistic regression model were chosen based on the characteristic data, and included the three patterns of PDs, gender, age, the use of AEDs, presence of clinical seizure, the five most common etiologies, and chronic epilepsy. Variables with a P value ≤ 0.1 in the univariate analysis were considered to be candidate variables for the multivariate regression models. The magnitude of association was reported as odds ratio (OR) and corresponding 95% confidence interval (CI). The predictive ability of the final model was quantified using area under the receiver operating characteristic curve analysis. A P value < 0.05 was defined as being statistically significant.
Results
Demographic data
From 1999 to 2015, we performed 15942 EEG recordings in inpatients and outpatients.
We initially identified 519 recordings in the database using the keyword search, representing a prevalence rate of 3.2% among all inpatient and outpatient EEG recordings. Of these, 99 duplicate studies were excluded. Thus, 420 patients in whom PDs were reported on at least one available EEG were enrolled in this study. The mean age of the patients was 66 ± 18.4 years (range, 6-99 years), and 205 (48.8%) were male.
Detailed etiologies, clinical seizure patterns, and functional outcomes of the patients are shown in Figure 1 . Systemic infection was the leading etiology of PDs (24%), followed by anoxic encephalopathy (15%) and ischemic stroke (12%). Other etiologies included metabolic disorders (8%), cefepime encephalopathy (8%), CNS infection (7%), Creutzfeldt-Jakob disease (5%), brain tumors (5%), hemorrhagic stroke (5%), trauma (4%), and carbapenem-induced encephalopathy (0.2%). We were unable to identify any acute etiology in 30 patients (7%). Of these patients, 22 (5%) had chronic epilepsy and the etiology was undetermined due to inadequate retrospective data in the other eight.
A total of 283 patients (67%) had at least one clinical seizure within 1 week after the appearance of PDs. The most common seizure pattern was generalized tonic-clonic seizures (GTCS; 35%), followed by simple partial seizures (SPS; 26%) and complex partial seizures (CPS, 9%). Of note, 84 patients (30%) had status epilepticus during the course of their illness.
The overall mortality rate during hospital admission was 37%, and the mean duration from EEG onset of PDs to mortality in these patients was 30 days (median: 17 days; range, 1-180 days). Of the remaining patients, 192 (46%) were classified as being dependent with regards to their activities of daily living, compared to only 74 (17%) who were classified as being independent.
Distribution of different PD patterns and clinical correlations
The distribution of different PD patterns and associated clinical characteristics are shown in Table 1 . Approximately half of the patients had LPDs (191, 45%), compared to 100 (24%) with BIPDs and 129 (31%) with GPDs. Systemic infection was the most common underlying etiology in all three groups. With regards to the individual etiologies, the patients with structural brain lesions such as ischemic stroke and trauma were more likely to develop LPDs, while those with diffuse encephalopathies such as anoxic encephalopathy, Creutzfeldt-Jakob disease and cefepime encephalopathy were more likely to have GPDs and BIPDs (all P < 0.01).
Clinical seizures were more frequently detected in the patients with LPDs (79%) compared to those with GPDs and BIPDs (both 58%, P < 0.001). However, there were no significant differences in the four seizure patterns among the three groups. Functional outcome analysis showed that the patients with GPDs and BIPDs had significantly higher mortality rates (44% to 46%) with only a 12% to 14% likelihood of an independent recovery. In comparison, the patients with LPDs had a lower probability of a fatal outcome (27%, P = 0.001).
Functional outcome predictors
Multiple factors correlated with mortality were identified and used to create the prediction model (Table 2) . Following univariate analysis of the predictors, nine variables met the inclusion criteria (P ≤ 0.1) for multivariate analysis. Old age (> 65 years) was the strongest independent predictor of mortality (OR = 2.55; 95% CI = 1.57-4.16; P < 0.001). Other factors including systemic infection, anoxic encephalopathy, cefepime encephalopathy, occurrence of status epilepticus, SPS and GTCS (compared with no seizures), presence of GPDs and BIPDs (compared with LPDs) were also significantly associated with mortality (all P < 0.05). The area under the ROC curve was 0.75. In contrast, the use of AEDs was inversely associated with mortality (OR = 0.50; 95% CI = 0.28-0.87; P = 0.02).
Consistent with the fatal outcome predictors, old age was a strong negative predictor for an independent recovery (Table 3 ). Other negative predictors for an independent outcome included the presence of GPDs and BIPDs, status epilepticus, systemic infection, and ischemic stroke (all P < 0.05).
AED treatment
Although only 67% of the patients had clinical seizures during hospitalization, 317 (75%) received AED treatment. The pattern of AED usage according to the type of discharge is shown in Table 4 . Levetiracetam, valproate and phenytoin were the three most common AEDs prescribed. In addition, 34 of 84 patients (37%) with status epilepticus were treated with intravenous midazolam infusion. Of note, 38 of 283 patients (13%) did not receive AED treatment despite having clinical seizures (Table 5) , the majority (23; 60.5%) of whom died. In contrast, AEDs were given to 72 of 137 patients (53%) without seizures, and only 22 of these patients died. The etiologies for those patients with clinical seizures but without AED treatment included systemic infection (9), cefepime encephalopathy (7), metabolic disorders (5), stroke (5), CNS infection (4), anoxic encephalopathy (4), tumor (3), and chronic epilepsy (1).
We further compared functional outcomes with the usage of AEDs and clinical seizures under different PD patterns (Table 5 ). In the patients with LPDs, the administration of AEDs was significantly associated with non-fatal outcomes, regardless of the presence of clinical seizures (P < 0.05). However, in the patients with BIPDs or GPDs, the administration of AEDs was not correlated with non-fatal outcomes in those with or without clinical seizures.
Discussion
The main finding of this study is that PDs were associated with a high rate of comorbidities and unfavorable functional outcomes. In addition, we identified several important prognostic factors, and showed that the use of AEDs was inversely associated with mortality, especially in the patients with LPDs.
The overall prevalence of PDs in our study was 3.2%, and about half of these PDs were LPDs (191 patients, 45%). This prevalence rate of LPDs is similar to other studies in the literature, with reported prevalence rates ranging from 0.1% to 1% in routine EEG (Chatrian et al., 1964; Fitzpatrick and Lowry, 2007; Garcia-Morales et al., 2002; Orta et al., 2009; Raroque et al., 1993b; Schraeder and Singh, 1980; Terzano et al., 1986; Walsh and Brenner, 1987 ).
However, the true incidence may be higher, as many patients with PDs may not receive an EEG, particularly those without seizures or altered levels of consciousness. Similarly, the true prevalence and incidence of BIPDs and GPDs may also be underestimated, with other studies reporting a prevalence of 0.09% to 0.1% for BIPDs and 0.06% for GPDs in routine EEG (Fitzpatrick and Lowry, 2007; Orta et al., 2009 ). In the current study, 0.63% of all patients who received routine EEG had BIPDs and 0.81% had GPDs.
It is generally agreed that LPDs are responses to acute or rapidly progressive processes and that they are usually associated with structural brain lesions, with the most common being cerebrovascular disease followed by tumors and CNS infections (Orta et al., 2009; Pohlmann-Eden et al., 1996; Walsh and Brenner, 1987) . This is consistent with our findings. In addition, with regards to toxic and metabolic factors (Garcia-Morales et al., 2002; Raroque et al., 1993a) we also identified several non-lesional entities which provided further insight into the etiology of PDs. First, systemic infection and anoxic encephalopathy were frequently associated with either BIPDs or GPDs, implying that diffuse encephalopathies were more associated with the occurrence of generalized periodic EEG patterns than stroke. Second, we also found that cefepime encephalopathy was an important etiology, especially in a critical setting. In previous reports, the most common EEG patterns of cefepime encephalopathy were GPDs and diffuse background slowing (Fugate et al., 2013; Naeije et al., 2011) . In addition to GPDs, we also observed both LPDs and BIPDs in about half of the patients. We therefore suggest that cefepime should be considered a cause of encephalopathy in patients with abnormal periodic EEG patterns, regardless of the subtype of the PD.
Recent clinical seizures occurred in 67% of our patients with PDs, which is consistent with previous studies (Fitzpatrick and Lowry, 2007; Garcia-Morales et al., 2002) . In 2009, Orta and colleagues reported that 59% of 152 patients with PDs had clinical seizures, and further subgroup analysis showed that seizures occurred in 70% of the patients with LPDs, 43% of the patients with BIPDs, and 29% of the patients with GPDs. Similarly, we also found that the patients with LPDs were more likely to have associated clinical seizures (79%) compared to those with BIPDs or GPDs (58% for both groups). Although previous studies have failed to demonstrate the prognostic value of seizures in the context of LPDs (Garcia-Morales et al., 2002) , the presence of SPS, GTCS and status epilepticus were associated with a poor outcome in our series. In addition to clinical seizures, increasing evidence suggests an association between the occurrence of electrographic seizures and worse outcomes (Sainju et al., 2015) . In this retrospective, observational cohort study, we were only able to collect routine EEG data, and thus the occurrence and predictive value of electrographic seizures could not be evaluated.
Since continuous EEG (cEEG) is frequently used due to its high detection rate (approximately 90%) of electrographic seizures in critically ill patients (Abend et al., 2010; Claassen et al., 2004; Hirsch, 2010) , further prospective studies with cEEG are warranted in order to identify associations between clinical and electrographic seizures and their predictive value with regards to functional outcomes in patients with PDs.
Although many studies have focused on the association between clinical seizures and PDs, it is still unclear whether these patterns represent ictal activity or simply nonspecific cerebral reactions. Significant controversy also exists regarding which patterns should be treated, and whether successful treatment improves clinical outcomes (Chong and Hirsch, 2005; Hirsch et al., 2013; Hughes, 2010; Koren et al., 2016) . A number of studies have considered these patterns to be "nonconvulsive status epilepticus", "a subtle status", or "partial status epilepticus" because of the periodically continuous nature. Several case reports of patients with PDs who underwent SPECT and PET studies support these conclusions, in which increases in regional cerebral blood flow, use of oxygen, and hypermetabolism were frequently associated with an ictal pattern (Ergun et al., 2006; Handforth et al., 1994; Lee and Schauwecker, 1988) .
On the other hand, some studies have not considered this waveform to be an ictal pattern, and some have even recommend no treatment due to a lack of clinical significance (Hughes, 2010) .
Some authors have also reported that controlling the underlying infection or inflammatory condition can abolish the PDs without requiring AED treatment (Maingueneau et al., 1999; Nakamura et al., 2002; Shimada et al., 1989) . However, other studies have reported an incidence rate of subsequent seizures ranging from 10% to 56% in adults with seizures at presentation and an EEG showing LPDs, whereas patients without seizures or LPDs were unlikely to develop a seizure disorder (Garcia-Morales et al., 2002; Schraeder and Singh, 1980; Walsh and Brenner, 1987) . Given the high risk of subsequent seizures in patients with both seizures and LPDs, Schraeder and Singh recommended that these patients should be treated with AEDs (Schraeder and Singh, 1980) . Chong and Hirsch proposed 1 month of prophylactic AED treatment in all patients with LPDs, irrespective of the occurrence of seizures (Chong and Hirsch, 2005) . Nevertheless, the association between AED treatment and functional outcomes has not previously been evaluated. Thirteen percent of our patients did not receive AED treatment despite having clinical seizures. Due to the retrospective nature of this study, data collection was based on a chart review which meant we were unable to clarify the decision making process as to why AEDs were not used for these patients, the majority (60.5%) of whom had a fatal outcome. Further etiology analysis revealed that most of these patients had underlying metabolic or infectious diseases, which may have precluded the clinicians from prescribing AEDs. This suggests that in addition to correcting underlying provoking factors, AEDs may be considered when seizures occur in patients with PDs, irrespective of the underlying etiology. Of particular importance, we found that the use of AEDs was a significantly negative predictor for mortality when all types of PD were analyzed collectively.
Subgroup analysis further demonstrated that the patients with LPDs were more likely to die without AED treatment. Although we cannot definitively conclude the ictal nature of LPDs, based on our observations, we agree with Schraeder and Singh that AED treatment should be used for patients with concurrent seizures and LPDs. However, we also suggest that AEDs may be considered for patients with LPDs even without clinical seizures after comprehensive benefit-risk assessments in order to improve the chance of survival.
Regarding the choice of AEDs, previous studies have reported on specific AEDs that were effective for PDs, including carbamazepine, valproate, felbamate, midazolam, and barbiturates (Beydoun et al., 2004; Hughes, 2010; Hughes and Fuller, 1995; Liberalesso et al., 2013; Rejdak et al., 2008; Terzano et al., 1986) . As more than half of the seizure types in the current study were either GTCS or status epilepticus, intravenous AEDs (levetiracetam, valproate and phenytoin) were selected in order to control the clinical seizures rapidly.
However, due to the observational and retrospective nature of this study, whether the type of AED affected the functional outcome could not be clarified. Further prospective studies may be warranted in order to elucidate this issue.
In terms of prognosis, we found high rates of morbidity and mortality relating to the occurrence of PDs. This was even more striking in the patients with BIPDs and GPDs, in whom the mortality rate was 44% to 46% compared with 27% in the LPD group. Although a case of benign BIPDs has been reported and a recent case-control study reported that GPDs had no definite independent prognostic value for a worse outcome (Foreman et al., 2012) , many studies have demonstrated that the clinical state and prognosis may be worse in patients with BIPDs and GPDs than in those with LPDs (Andraus et al., 2012; Foreman et al., 2012; Orta et al., 2009 ). Similar to our observations, Fitzpatrick and Lowry demonstrated an overall mortality rate of 27% in all patients with PDs, with a higher mortality rate of 52% in those with BIPDs (Fitzpatrick and Lowry, 2007) . In addition, Orta and colleagues retrospectively analyzed 118 patients with PDs and failed to demonstrate the prognostic value of various clinical factors when all types of PDs were analyzed together. However, the absence of clinical seizures at onset and an acute etiology were associated with mortality in the LPD subgroup (Orta et al., 2009) . We identified several important prognostic factors which have not been fully described before, including old age which was the strongest predictor of mortality, and systemic infection, anoxic and cefepime encephalopathy, status epilepticus, SPS, GTCS, GPDs and BIPDs, which were also prognostically unfavorable. However, it is important to note that outcome assessments in our and the previous studies were mostly retrospective, and the timing of functional outcome assessments was not consistent. Thus, further prospective studies with outcome assessments at different time points are warranted.
The strengths of this study include the use of a well-defined cohort with more than 15 years of data allowing for thorough evaluation of the characteristics of PDs and the use of regression analysis to validate the predictors more precisely. However, there are several limitations to this study. First, the retrospective nature of the data may have introduced selection bias towards patients in whom clinicians had reason to order EEG recordings and may not accurately reflect the true frequency of various patterns and seizures than if the study had included all patients. Second, patients may have been missed due to the limitations of the keyword search. However, we believe that this should not affect our main conclusions regarding periodic patterns because no systemic biases were found. Third, most of our patients received AED treatment regardless of whether or not they had clinical seizures, and the use of AEDs was associated with a lower rate of mortality. However, due to the retrospective design of our study, we were unable to clarify the reasons why 53% of the patients without clinical seizures were given AEDs, while 13% of the patients with clinical seizures did not receive AEDs. Fourth, outcome assessments were performed either at discharge or at an outpatient clinic visit within 1 month after the diagnostic EEG, and thus we cannot comment on longterm functional decline or on the development of epilepsy. Further prospective studies with a longer duration and outcome assessments at different time points (i.e. acute, subacute, or chronic) are warranted to examine in detail associations between PDs and functional outcomes.
Finally, we chose to include the leading cause of PDs as the main etiology, and this may have neglected other structural brain lesions if there were no available brain images.
Conclusions
In this study, PDs were detected in 420 patients who underwent EEG recording during a 17-year study period, and they were associated with worse functional outcomes and high rates of comorbidities. Old age was the strongest predictor of mortality, followed by systemic infection, anoxic encephalopathy, cefepime encephalopathy, and the occurrence of status epilepticus; whereas AED treatment was the only negative predictor of mortality. Our results suggest that AED treatment should be promptly initiated once PDs have been identified, especially in patients with associated comorbidities.
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